CDC panel recommends lifting Johnson & Johnson vaccine pause, advises added label

A Centers for Disease Control and Prevention panel voted on Friday to recommend lifting a pause on the use of Johnson & Johnson's COVID-19 vaccine in the United States, reports The New York Times. The panel decided there should be an added label to note the blood clotting disorder that has emerged as a rare side effect of the vaccine.
The CDC said there have been 15 confirmed reports of blood clots following Johnson & Johnson vaccinations, out of nearly 8 million doses administered in the U.S., reports ABC News. All 15 cases were in women, mostly women in their 30s, and three of the women died. After six cases were reported, the FDA and CDC called for a pause of the vaccine on April 13 "out of an abundance of caution."
The panel determined the benefits of the vaccine outweigh the seemingly rare risk, and will advise the CDC on its decision accordingly. Health officials are expected to follow the advisory and recommend that states begin using the vaccine again immediately.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Read more at The New York Times and ABC News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
TV to watch in April, including 'The Last of Us' and 'The Rehearsal'
the week recommends The zombie virus persists, Nathan Fielder investigates plane crashes and a cancer patient craves sexual discovery
By Anya Jaremko-Greenwold, The Week US Published
-
'Newsom has effectively assumed the presidency'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What is the job market's future after Trump's tariffs?
Talking Points Economic analysts are split on what the tariffs could mean for employees
By Justin Klawans, The Week US Published
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US Published
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published